To tackle one of the most important opportunities for society this decade—mitigating climate change by lowering greenhouse gas emissions from farming—Elanco Animal Health Incorporated and Royal DSM have formed a strategic cooperation. Elanco is the sole license holder in the United States for the development, production, and marketing of Bovaer® for dairy and beef cattle.
A groundbreaking, long-term strategic research and commercial agreement has been announced by Nutreco and BiomEdit to provide livestock farmers with cutting-edge and genuinely new feed additives created by microbiome technology. Through the agreement, the most cutting-edge microbiome biotech firm for animal health, BiomEdit, and Nutreco Exploration (NutEx), Nutreco's team tasked with developing patented ultra-specialty ingredients to promote its aim of Feeding the Future, are brought together.
Author Credits: Parul Atri
Report ID: 3159
Published Date: Jan 03, 2024
Report Format: PDF, PPT
Frequently Asked Questions (FAQ)
Increasing demand for animal meat and increased focus on the development of cattle health are some of the significant factors expected to drive the market growth.
The market size of beta agonist feed additives is anticipated to attain a CAGR of 4% over the forecast period, i.e., 2024-2036.
The major players in the market are Quality Liquid Feed Quality Liquid Feeds, Zoetis Services LLC, Intervet Inc. (Merck & Co. Inc.), ForFarmers, De Heus Animal Nutrition, Cargill, Incorporated., BASF SE, Zydus Group, Nutreco, Huvepharma Japan Co., Ltd. and others.
The ractopamine segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.
The market in the North American region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.